Cipla to sell Lilly's Trulicity, Humalog diabetes treatments in India - NewsBreak

BENGALURU (Reuters) - India's Cipla has signed a deal with Eli Lilly to sell and distribute two of the U.S. drugmaker's best-selling diabetes treatments in the country, the companies said in a joint statement on Monday. Lilly will transfer its rights in India to sell, promote and distribute its Trulicity...